The historical rank and industry rank for bioAffinity Technologies's Price-to-Tangible-Book or its related term are showing as below:
BIAF'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.21 Med: 3.24 Max: 7.17
Current: 7.14
During the past 4 years, bioAffinity Technologies's highest Price to Tangible Book Ratio was 7.17. The lowest was 1.21. And the median was 3.24.
BIAF's Price-to-Tangible-Book is ranked worse than 83.23% of 167
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.5
vs BIAF: 7.14
bioAffinity Technologies Price-to-Tangible-Book Historical Data
The historical data trend for bioAffinity Technologies's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of bioAffinity Technologies's Price-to-Tangible-Book
For the Diagnostics & Research subindustry, bioAffinity Technologies's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
bioAffinity Technologies's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, bioAffinity Technologies's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where bioAffinity Technologies's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
bioAffinity Technologies Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of bioAffinity Technologies's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
bioAffinity Technologies (bioAffinity Technologies) Business Description
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company is involved in developing technologies that, in the future, will be able to detect and monitor diseases of the lung and other cancers and treat many cancers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BIAF has been successfully added to your 